Skip to content

A review of problems that happened after surgery in patients who had HIPEC (a surgical procedure that treats certain abdominal cancers)

A retrospective analysis of postoperative complications in Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy surgery: [CHERRY (Complications of HipEc suRgeRY)] - CHERRY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/079852
Enrollment
400
Registered
2025-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C76-C80- Malignant neoplasms of ill-defined, other secondary and unspecified sites Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Nil: NA Control Intervention1: Nil: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adults who have undergone CRS-HIPEC surgeries in the study period both for primary and recurrence.

Exclusion criteria

Exclusion criteria: Patients with incomplete dataset

Design outcomes

Primary

MeasureTime frame
Incidence of Grade 3 & 4 Clavien Dindo Complications and as per Comprehensive Complication Index (CCI) following HIPEC surgery Medical complications 1) Respiratory complications 2) Cardiovascular complications 3) Renal and pelvicalyceal system complications 4) Central nervous system complications like delirium etc 5) Hepatobilliary and gastrointestinal complications 6) Hematological complications 7) Sepsis: cause by central line, foleys catheter etc 8) Venous thromboembolism: pulmonary embolism and deep venous thrombosis 9) others Surgical complications 1) Intra-abdominal complications like Gastrointestinal anastomotic leak, fistula. 2) Stoma complications 3) Abdominal wall / surgical site complications 4) Need of reexploration 5) Radiological intervention like pigtail insertionTimepoint: Until hospital discharge

Secondary

MeasureTime frame
1) Need of Invasive mechanical ventilation more than 24 hours 2) Need of ICU admission more than 3 days 3) Mortality at 30 days and 90 days Timepoint: Until hospital discharge

Countries

India

Contacts

Public ContactDr Atul Kulkarni

Tata Memorial Centre

kaivalyaak@yahoo.co.in9869077526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026